- Report
- February 2024
- 110 Pages
Global
From €5300EUR$5,950USD£4,522GBP
- Report
- January 2024
- 150 Pages
Global
From €5300EUR$5,950USD£4,522GBP
- Report
- October 2023
- 195 Pages
Global
From €5300EUR$5,950USD£4,522GBP
- Report
- March 2023
- 134 Pages
Global
From €5300EUR$5,950USD£4,522GBP
- Report
- May 2024
- 70 Pages
United States
From €3518EUR$3,950USD£3,002GBP
- Report
- May 2024
- 120 Pages
Global
From €5300EUR$5,950USD£4,522GBP
- Report
- June 2023
- 180 Pages
Global
From €5300EUR$5,950USD£4,522GBP
- Report
- July 2018
- 108 Pages
Global
From €1327EUR$1,490USD£1,132GBP
- Report
- February 2024
- 175 Pages
Global
From €2227EUR$2,500USD£1,900GBP
- Report
- October 2023
- 166 Pages
Global
From €2227EUR$2,500USD£1,900GBP
- Report
- December 2021
- 120 Pages
Global
From €2227EUR$2,500USD£1,900GBP
- Report
- May 2024
- 302 Pages
Global
From €4454EUR$5,000USD£3,800GBP
- Report
- May 2024
- 184 Pages
Global
From €3407EUR$3,825USD£2,907GBP
€4008EUR$4,500USD£3,420GBP
- Report
- May 2024
- 185 Pages
Global
From €3407EUR$3,825USD£2,907GBP
€4008EUR$4,500USD£3,420GBP
- Report
- May 2024
- 187 Pages
Global
From €3407EUR$3,825USD£2,907GBP
€4008EUR$4,500USD£3,420GBP
- Report
- February 2024
- 187 Pages
Global
From €3407EUR$3,825USD£2,907GBP
€4008EUR$4,500USD£3,420GBP
- Report
- November 2023
- 190 Pages
Global
From €3407EUR$3,825USD£2,907GBP
€4008EUR$4,500USD£3,420GBP
- Report
- October 2023
- 89 Pages
Canada
From €2650EUR$2,975USD£2,261GBP
€3118EUR$3,500USD£2,660GBP
- Report
- October 2023
- 175 Pages
Global
From €3407EUR$3,825USD£2,907GBP
€4008EUR$4,500USD£3,420GBP
- Report
- July 2023
- 78 Pages
United States
From €2650EUR$2,975USD£2,261GBP
€3118EUR$3,500USD£2,660GBP

The Biomarkers market is a sector of the healthcare industry that focuses on the development and use of biomarkers for the diagnosis, prognosis, and treatment of diseases. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. They can also be used to predict the response to a particular treatment. Biomarkers are typically proteins, nucleic acids, or metabolites that are found in the body and can be measured in a variety of ways.
Biomarkers are used in a variety of medical applications, including cancer diagnosis and treatment, cardiovascular disease, and neurological disorders. They are also used in drug development, to identify potential drug targets and to monitor the safety and efficacy of drugs.
Some of the major companies in the Biomarkers market include Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. Show Less Read more